Against the backdrop of the 43rd Annual J.P. Morgan Healthcare Conference, Mayo Clinic announced the formation of Mayo Clinic Digital Pathology, designed on a platform architecture to boldly unlock ...

Continue to advance preclinical and research pipeline, including key programs selectively combined with Alector Brain Carrier, enhancing the ...

A recent study has linked thyroid and liver proteins, transthyretin (TTR) and apolipoprotein A-I (ApoA-I), to brain health, ...

Researchers at Nanyang Technological University in Singapore have identified a new “energy switch” in immune cells of the ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

The agreement with China Medical System Holdings Limited is for the development, manufacturing, and commercialization of ...

Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...

Company to Present Breakthrough Research Approach for a New Generation of Neurodegenerative Therapeutics GAINESVILLE, Fla., ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Their Phase 2a clinical trial of Hoth's topical gel HT-001 has shown 100% success in combating skin toxicities caused by ...

For years, researchers have debated the root cause of Alzheimer’s. Two main theories dominate the discussion. The first ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...